Compound Detail
CHEMBL807
MEMANTINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL807 |
| Name | MEMANTINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | BUGYDGFZZOZRHP-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
15
Targets
59
Activities
3
Assay Types
2
PK Parameters
20
Publications
5
Known Names
20
Indications
Molecular Properties
179.3
MW (Da)
2.69
ALogP
1
HBA
1
HBD
26.0
PSA (Ų)
0.61
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2002 |
| Availability | Prescription |
| Chirality | Racemic |
Indications
Dementia Alzheimer Disease Anxiety Bipolar Disorder Child Development Disorders, Pervasive Cognitive Dysfunction Cognitive Dysfunction Depressive Disorder Fibromyalgia Glaucoma, Open-Angle Ischemic Stroke Migraine Disorders Multiple Sclerosis Obsessive-Compulsive Disorder Pain Parkinson Disease Schizophrenia Substance-Related Disorders Substance-Related Disorders Tension-Type Headache
ATC Classification
N06DX01
memantine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOANALEPTICS
Activity Summary
IC50 44 meas. best 9.02
Ki 13 meas. best 6.37
EC50 2 meas. best 5.61
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Glutamate NMDA receptor; GRIN1/GRIN2A CHEMBL1907604 | IC50 | 9.02 | 6.0333 | 0.9 | 6 |
| Acetylcholinesterase CHEMBL220 | IC50 | 8.31 | 7.21 | 4.9 | 2 |
| Unchecked CHEMBL612545 | IC50 | 6.65 | 5.7238 | 222.0 | 13 |
| Unchecked CHEMBL612545 | Ki | 6.37 | 5.9375 | 429.0 | 8 |
| Glutamate [NMDA] receptor CHEMBL2094124 | Ki | 6.27 | 6.1533 | 540.0 | 3 |
| Glutamate receptor ionotropic, NMDA 2C CHEMBL401 | Ki | 6.16 | 6.16 | 700.0 | 1 |
| SH-SY5Y CHEMBL614910 | IC50 | 6.14 | 6.14 | 718.0 | 1 |
| Glutamate NMDA receptor; GRIN1/GRIN2B CHEMBL1907603 | Ki | 6.0 | 6.0 | 1000.0 | 1 |
| Glutamate NMDA receptor; Grin1/Grin2a CHEMBL2096680 | IC50 | 6.0 | 5.79 | 1000.0 | 2 |
| Glutamate NMDA receptor; GRIN1/GRIN2B CHEMBL1907603 | IC50 | 5.99 | 5.3875 | 1020.0 | 4 |
| Glutamate NMDA receptor CHEMBL1907608 | IC50 | 5.96 | 5.236 | 1090.0 | 10 |
| Cerebellar granule neurone CHEMBL614452 | EC50 | 5.61 | 5.61 | 2480.0 | 1 |
| Glutamate receptor ionotropic, NMDA 1 CHEMBL330 | EC50 | 5.57 | 5.57 | 2720.0 | 1 |
| Glutamate NMDA receptor; Grin1/Grin2b CHEMBL2096666 | IC50 | 5.25 | 5.25 | 5570.0 | 1 |
| Nicotinic acetylcholine receptor alpha6/alpha3/beta4 CHEMBL3137276 | IC50 | 5.22 | 5.22 | 6000.0 | 1 |
| Trypanosoma brucei CHEMBL612849 | IC50 | 4.86 | 4.86 | 13750.0 | 2 |
| Solute carrier family 22 member 1 CHEMBL5685 | IC50 | 4.57 | 4.57 | 27200.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| F | 100.0 | % | Homo sapiens |
| T1/2 | 60.0 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine